A quick guide to evidence-based chronic kidney disease care for the primary care physician

Area of Science:

• Nephrology
• Public Health
• Internal Medicine

Background:

• Increasing prevalence of chronic kidney disease (CKD) in the US, linked to aging population and comorbidities like hypertension, diabetes, and obesity.
• CKD is a significant risk factor for cardiovascular disease, with most patients dying from heart disease before reaching end-stage renal disease.
• Existing evidence-based guidelines (KDOQI) for CKD management are underutilized due to complexity and length.

Purpose of the Study:

• To synthesize key evidence-based behaviors and clinical action plans for primary care physicians (PCPs) to manage CKD.
• To provide PCPs with actionable strategies to delay CKD progression and prevent complications.
• To improve the uptake and implementation of CKD management guidelines in primary care settings.

Main Methods:

• Review and synthesis of evidence-based behaviors and clinical guidelines for CKD management.
• Identification of key screening tests: estimated glomerular filtration rate (eGFR) and urinary albumin-creatinine ratio (UACR).
• Focus on actionable strategies for PCPs to diagnose, stage, and treat CKD and its complications.

Main Results:

• CKD affects 13.1% of the US population, with significant morbidity and healthcare costs.
• Screening for CKD is recommended for individuals with risk factors including hypertension, diabetes, cardiovascular disease, family history, and age over 60.
• eGFR and UACR tests are crucial for CKD diagnosis and staging into 5 stages.

Conclusions:

• Primary care physicians play a vital role in managing the rising burden of CKD.
• Implementing evidence-based screening and management strategies can delay CKD progression and reduce complications.
• Simplified clinical action plans derived from KDOQI guidelines are needed to enhance PCP adoption and improve patient outcomes.